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Abstract It is suggested that gastric mucins, and in par-
ticular some specific glycan structures that can act as car-
bohydrate receptors, are involved in the interactions with
Helicobacter pylori adhesins. The main aim of our study
was to evaluate glycosylation pattern of glycoproteins of
gastric juice before and at the end of eradication therapy.
Gastric juices were taken from 13 clinical patients and
subjected to analysis. Pooled fractions of the void volume
obtained after gel filtration were subjected to ELISA tests.
To assess the relative amounts of carbohydrate structures,
lectins and monoclonal antibodies were used. Changes in
the level of MUC 1 and MUC 5AC mucins and of carbo-
hydrate structures, which are suggested to be receptors
for Helicobacter pylori adhesins, were observed by the
end of the eradication treatment. Our results support
the idea about the involvement of MUC 5AC and MUC 1
with some specific sugar structures in the mechanism of
Helicobacter pylori infection.
Keywords Gastric juices  Glycosylation  Lectins 
MUC 1 mucin  MUC 5AC mucin
Introduction
It is believed that gastric mucus gel layer forms an effec-
tive protective barrier against various pathogens, such as
Helicobacter pylori, the major etiological agent of chronic
gastritis, peptic ulcers, and gastric cancers [1–3]. The main
components of mucus are the heavily O-glycosylated pro-
teins known as mucins. Three of them are present in human
stomach. MUC 5AC and MUC 6 mucins are all secreted
into gastric juice; the former being expressed by the surface
epithelium and the latter by the deeper antrum gland epi-
thelium [4]. In addition, the epithelial membrane-associ-
ated MUC 1 mucin is also present in the stomach [5]. The
glycans in mucins are mainly O-linked with blood group
antigens often present terminally. Mucin-type oligosac-
charides are structurally very diverse; the glycans in the
same molecule can exhibit a high degree of subtle varia-
tions in their structure depending on dynamic physiological
and pathological biochemical conditions that exist in the
body at the time when the structures are formed [6]. The
glycosyltransferases expressed by the individual determine
glycan profiles of mucins in that individual [7].
Helicobacter pylori can colonize gastric epithelium by
interactions with carbohydrates receptors [8]. Lewis b
structure is one of the known receptors for bacterial
adhesins (BabA–the blood group antigen–binding adhesin),
and it is considered that MUC 5AC mucin is the main
carrier of this structure [8, 9]. Some other glycoform
structures (e. g. H type 1 structure, sialyl Lewis x) are also
suggested to be implicated in binding with H. pylori
adhesins [10–12]. It has been recently proposed that apart
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from MUC 5AC mucin, also MUC 1 can be carrier of
receptors for bacterial adhesins and can be involved in
development of infection [7, 13, 14]. There are suggestions
that changes in glycoforms can affect the protective func-
tions of gastric mucins and H. pylori colonization. It is
postulated that alterations that occur during H. pylori
infection are completely reversed after eradication [14].
The main aim of our study was to check whether there
are changes in the pattern of glycosylation of the mucins of
gastric juice before and after eradication of H. pylori. We
assumed that carbohydrates present in gastric juice origi-
nate from gastric mucosa. Among them, there are secreted
MUC 5AC mucin and soluble form of membrane-bound
MUC 1. We suppose a parallel relationship between MUC
1 cell membrane expression and its shedding to gastric
juice. To test the changes in glycosylation, we used ELISA
method with monoclonal antibodies against gastric mucins




Thirteen Helicobacter pylori–infected patients with duode-
nal ulcers (9 men, 4 women; age range 24–60, mean age 44),
hospitalized in the Department of Medicine and Gastroen-
terology of Regional Hospital of Białystok, Poland,
were included in the study. Each patient was treated for
2 weeks with oral administration of omeprazole (2 9 20 mg
per day), amoxiciline (2 9 1,000 mg), and tynidazole
(2 9 500 mg). All subjects were on standard hospital diet
served for the peptic ulcer patients. The tested gastric juices
were taken before and on days 11–13 of the treatment. They
were collected by aspiration for 15 min with a gastric catheter
inserted through the nares. The procedure was performed
in the morning hours after overnight fasting. At the first
gastric test, no drugs were allowed for at least 14 days, at the
second gastric test the last doses of the drugs (omeprazole,
amoxicillin, and tinidazole) were taken in the evening pre-
ceding the day of the examination.
The presence of the bacterium was examined histolog-
ically and by urease test with gastric cells scraped under
endoscopic examination. It was done before and at the end
of the treatment. The eradication therapy was successful in
all the patients at the second endoscopy assessment.
Enzyme-linked immunosorbent assay
The juice was initially treated as described before [15].
High molecular mass material obtained in the void volume
after gel filtration was subjected to further analysis. To
assess relative amounts of carbohydrate structures in
examined material, ELISA tests with monoclonal anti-
bodies and biotinylated lectins were performed. Specifi-
cations of antibodies employed in this study are listed in
Table 1. For carbohydrate specificity of lectins, see
Table 2. Samples of gastric juices were diluted to the
identical protein concentration 5 lg/mL, and aliquots (50
lL) were coated onto microtiter plates (NUNC F96;
Maxisorp, Roskilde, Denmark) at room temperature over-
night. The protein content was determined using bicinch-
oninic acid [16]. The plates were washed 3 times (100 lL)
with PBS, pH 7.4, 0.05% Tween (PBS-T; washing buffer)
between all ensuing steps. Unbound sites were blocked
with 100 lL of 1% blocking reagent for ELISA (Roche
Diagnostics, Mannheim, Germany) for 1 h. The microtiter
plates were incubated with 100 lL of biotinylated lectins
(1 h) diluted to 0.5 lg/mL in PBS-T, 1% bovine serum
albumin, BSA (Sigma, St Luis, MO, USA). Some lectin
solutions were supplemented with metal cations: DSA,
UEA, SNA, LTA, PNA, and GNA with 0.1 mmol/L CaCl2;
MAA and VVA with 0.1 mmol/L CaCl2 and 0.01 mmol/L
MnCl2. Plates were then incubated with 100 lL of horse-
radish peroxidase avidin D (Vector, Burlingame, CA,
USA) (1 : 2 500) in PBS-T, 1% BSA for 1 h. Next, plates
were washed 4 times in PBS, and the colored reaction was
developed by incubating with 2,20-azino-bis(3-ethyl-
benzthiazoline-6-sulfonic acid) (ABTS)–liquid substrate
Table 1 Sources of antibodies
used in this study
Antibody Clone Source Final
dilution
MUC 1 (anti-human episialin–EMA) GP1.4 SIGMA 1:400
MUC 5AC 45M1 SIGMA 1:400
Lewis b LWB01 LAB VISION 1:1,500
Sialyl Lewis x KM93 CHEMICON 1:500
H type 1 17-206 ABCAM 1:500
Horseradish peroxidase–conjugated rabbit anti-mouse IgG SIGMA 1:1,500
Horseradish peroxidase–conjugated goat anti-mouse IgM
(l-chain specific)
SIGMA 1:1,500
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for horseradish peroxidase (Sigma, St Luis, MO, USA).
Absorbance at 405 nm was measured after 30–45 min. For
analysis with monoclonal antibodies (diluted in washing
buffer, 1% BSA), the plates were coated with 100 lL of
antibody for 1 h. Next, they were incubated with secondary
antibody, horseradish peroxidase–conjugated anti-mouse
IgG (for anti-MUC 1, MUC 5AC, Lewis b, and H type 1
structures) or anti-mouse IgM (for anti-sialyl Lewis x
structure). The colored reaction was developed as men-
tioned earlier. As controls wells with no gastric juices were
used.
Statistical analyses
The relative amounts of examined structures (based on
absorbance at 405 nm obtained from ELISA tests) were
subjected to statistical analysis (by STATISTICA 7.1
StatSoft program). All the data revealed normal distribu-
tion, and two-sided t-test was used. Statistical significance
was assumed at P \ 0.05. Pearson’s correlations of two
variables (the relative amounts of MUC 1 and MUC 5AC
mucins before and at the end of the treatment versus the
relative amounts of examined carbohydrate structures
before and at the end of the therapy) were calculated.
The study was approved by the Institutional Ethical
Committee and conducted according to the principles of
the Declaration of Helsinki. Informed consent was obtained
from all the patients.
Results
Juices from 13 patients were divided into two groups:
before eradication and at the end of eradication therapy
(11–13 day of the treatment). High molecular mass mate-
rial of void volume obtained after gel filtration of gastric
juices was taken for glycan analysis.
Glycans of all gastric juices examined revealed reac-
tivity with monoclonal antibodies (Fig. 1) and lectins
(Fig. 2) employed in this study. The analysis of the inter-
actions of gastric juices with specific anti-MUC 1 and
MUC 5AC monoclonal antibodies revealed higher levels of
both mucins in juices at the end of eradication treatment. In
case of MUC 1, the difference was statistically significant
(P = 0.000066) (Fig. 3).
The relative amounts of specific carbohydrate structures
Lewis b, sialyl Lewis x, and H type 1 recognized by
monoclonal antibodies were found to be higher at the end
of eradication therapy. For sialyl Lewis x and H type 1
Table 2 The major binding
specificities of used lectins
Origin and used abbreviation of lectin Binding preference
Areulia auranta (AAA) Fuca1-6GlcNAc; Fuca1-2Gal; Fuca1-3GlcNAc [25]
Ulex europaeus (UEA) Fuca1-2Gal; Fuca1-3GlcNAc [26]
Lotus tetragonolobus (LTA) Fuca1-3GlcNAc [27]
Maackia amurensis (MAA) NeuAca2-3Gal [28]
Sambucus nigra (SNA) NeuAca2-6Gal/GalNAc [29]
Arachis hypogaea (Peanut) (PNA) Galb1-3GalNAc (T-antigen) [30]
Vicia villosa (VVA) GalNAc (Tn-antigen) [31]
Datura stramonium (DSA) Galb1-4GlcNAc; GlcNAc [32]
Narcissus pseudonarcissus (NPA) a-1,6 mannose residues [33]
Galanthus nivalis (GNA) a-1,3 mannose residues [34]
Fig. 1 Reactivity with monoclonal antibodies (at 405 nm). a juices
before eradication treatment (n = 13); b juices at the end of
eradication therapy (n = 13). The points are connected for those that
belong to the same sample
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structures, the differences were statistically significant
(P = 0,00208 and 0.00209 for sialyl Lewis x and H type 1,
respectively) (Fig. 3).
Fucosylation profile was examined by LTA, UEA, and
AAA lectins. The lowest amount was observed for Fuc a 1-
3 bond. The relative amounts of all fucosylated structures
were higher at the end of eradication treatment. The dif-
ferences were statistically significant for AAA and UEA
lectins (P = 0.000124 and 0.03475, respectively) (Fig. 4).
SNA and MAA are lectins specific for sialic acid. The
analysis of interactions of these lectins with glycoproteins
of juices showed a little higher amount of SA a 2–3
than SA a 2–6 linkage. In both cases, higher level of
these specific structures was observed at the end of the
treatment with statistically significant difference for SNA
(P = 0.003475) (Fig. 4).
PNA and VVA lectins recognize T and Tn antigens,
respectively. The results of our analyses revealed almost
the same level of binding of both lectins to glycans present
in two examined groups of juices (Fig. 4).
The relative amounts of complexes formed between
sugar structures of gastric juices and DSA lectin (specific
for Gal b 1–4 GlcNAc-R and GlcNAc-R linkages) were
significantly higher after eradication treatment (P = 0.011)
(Fig. 4).
NPA and GNA are lectins with specificity toward a 1–6
and a 1–3 linked mannose, present especially in N-glyco-
proteins. The relative amounts of above linkages were low
in comparison with bonds revealed by other lectins, with
very similar level before and at the end of eradication
treatment (Fig. 4).
Pearson’s correlations between the amounts of exam-
ined sugar structures and the amounts of MUC 5AC and
MUC 1 mucins in juices before treatment and at the end of
eradication therapy were calculated. Mostly, the correla-
tions between mentioned structures in two examined
groups of juices were rather low. Moderate and high cor-
relations in both groups of juices were found between the
amounts of MUC 1 and H type 1 structure (r = 0.39 and
0.87 for juice before and at the end of the treatment,
respectively). Such positive correlations were also revealed
between MUC 5AC and structure recognized by SNA
lectin (r = 0.47 and 0.46 for juice before and at the end of
the treatment) and between MUC 5AC and structure rec-
ognized by LTA and UEA lectins (r = 0.8 and 0.48 for
LTA and 0.39 and 0.32 for UEA for juice before and at the
Fig. 2 Reactivity with lectins (at 405 nm). a juices before eradica-
tion treatment (n = 13); b juices at the end of eradication therapy
(n = 13). The points are connected for those that belong to the same
sample
Fig. 3 Comparison of
reactivity with monoclonal
antibodies in juices before and
the end of eradication therapy.
Bars represent the mean ± SD
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end of the eradication therapy, respectively). In case of
MUC 5AC and Lewis b structure, correlations were also
positive in both juices (r = 0.27 and 0.46). The values of
all coefficients together with their statistical significances
are summarized in Table 3.
Discussion
Analyses of carbohydrates of gastric juices before and at
the end of eradication therapy revealed alterations caused
likely by H. pylori infection. Because the examined
material was taken from the void volume after gel filtra-
tion, we assume that analyzed structures originate mostly
from high molecular mass mucins. Two mucins, MUC 1
and MUC 5AC, which are suggested to be involved in the
mechanism of the infection, were analyzed. MUC 5AC is
secretory one and can be normally present in gastric juice.
MUC 1 is membrane-bound mucin, but it can be cleaved
by host cell proteases and released to juice from gastric cell
surface [17]. The higher level of both mucins was observed
at the end of the treatment, which is in accordance with the
results of some other investigations which revealed that H.
pylori inhibits total mucin synthesis in gastric epithelial
cells [18–20]. It is suggested that protective ability of
gastric mucins may depend largely on their oligosaccharide
chains. Alterations in the glycosylation pattern induced by
the infection can impair the protective function of mucins.
An increased level of MUC 1 mucin after eradication
treatment was also observed in our earlier investigations
when we examined this structure and also Lewis b and a
blood group antigens using Western blotting and densi-
tometry [15, 21].
Our results revealed increased level at the end of erad-
ication therapy for only of those carbohydrate structures
that are proposed to be involved in the interactions with
H. pylori adhesins. The expression of fucosylated glycans
was examined by anti-Lewis b, anti-H type 1 monoclonal
antibodies, and AAA, UEA, and LTA lectins. Fuc a 1–2
linkage, which seems to be the most abundant, is present
especially in peripheral Gal residues, which can be easily
available for bacterial adhesins. Fuc a 1–2 bond is present
in Lewis b and H type 1 structures, and these glycans were
also observed in higher level at the end of the treatment.
Therefore, our results support hypothesis about involve-
ment of Lewis b and H type 1 structures in interactions
with H. pylori [7–9, 11]. The depletion of these antigens in
the infectious state might promote infection by enhancing
the access of the bacterium to the epithelial surface [18].
Another explanation can also be taken into account. The
decreased level of these possible bacterial receptors that
can be located in MUC 1 and MUC 5AC mucin is sug-
gested to be a kind of host defense. Some authors propose
hypothesis with MUC 1 as a releasable decoy ligand for H.
pylori that can be released from cell surface together with
the adhered bacterium [7, 18]. Carbohydrate structures of
MUC 1 mucin that possess long filamentous extracellular
domain are considered to be the point of first direct contact
between host cells and pathogenic organisms that penetrate
the secreted mucus layer.
It is said that sialylated glycan structures are not typical
for gastric mucins; they account for only about 3% of the
total oligosaccharides (present in MUC 5AC mucin) [18],
but they are also considered by some authors as potential
receptors for bacterial adhesins [10, 12]. Sialylated forms
are characteristic in H. pylori–infected specimens, and they
decrease after eradication [10]. Surprisingly, in our study
for both examined kinds of linkages, SA a 2–3 and SA a
2–6, the increased level in the recovered state was revealed.
It is likely that high level of sialylation is due to the
presence of highly sialylated, salivary MUC 5B mucin in
gastric juice [22]. However, it was not explored in our
study. The increase in sialyl Lewis x structure (with a SA
2–3 bond; recognized by monoclonal antibody) at the end
Fig. 4 Comparison of
reactivity with lectins in juices
before and the end of
eradication therapy. Bars
represent the mean ± SD
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of eradication therapy was significantly higher than that for
SA a 2–3 bond detected by MAA lectin. This discrepancy
can be explained by higher specificity of monoclonal
antibodies than lectins during detection. Sialylation
through a 2–6 bond is typical especially for short core
carbohydrate structures and in our experiments was
detected in low level, although with slight increase at the
end of the therapy.
Gal b 1-4 GlcNAc structure (detected by DSA lectin),
typical for O-glycosylated mucins, found also in sialyl
Lewis x glycoform, was more abundant at the end of
eradication treatment. This result is in accordance with
general tendency of the increased level of examined mucins
and glycoforms involved in interactions with H. pylori at
the end of the treatment.
We observed no influence of the infection on the levels
of short Tn and T carbohydrate structures. This result
confirms the proposal that H. pylori influences only the
peripheral sugar structures. Mannose residues, not typical
in O-glycosidic chains, were detected in very low levels.
These probably originate from rare N-glycosidic oligo-
saccharides that can be present in mucins [17].
As the mechanism of H. pylori infection has not been
elucidated thoroughly, it is difficult to explain the mecha-
nism of alterations induced by the bacterium. One possible
explanation is that H. pylori can change the expression of
genes involved in glycan synthesis such as transferases,
crucial for the biosynthesis of potential bacterial receptors
[18]. Interesting hypothesis about kind of relationship
between two mucins (MUC 5AC and MUC 1) likely
involved in the mechanism of infection has been proposed.
MUC 5AC as more abundant one may at first catch Helico-
bacter pylori and then deliver it to the membrane-associated
MUC 1 mucin. This mucin can cause signal transduction
over the epithelial barrier and act as a releasable decoy. In
this way, mucins together with the bacterium can be flushed
away (Fig. 5) [7, 23]. The level of both mucins, with some
specific sugar structures, acting as receptors for bacterial
adhesins, decreases. These alterations are completely
reversed after eradication [14].
Table 3 Pearson’s coefficients
calculated for two variables (the
relative amounts of MUC 1 and
MUC 5AC mucins before and at
the end of the treatment versus
the relative amounts of
examined carbohydrate




r = 1—perfect correlation;
0.75 B r \ 1—high degree of
correlation; 0.25 B r \ 0.75—
moderate degree of correlation;
0 \ r \ 0.25—low degree of








Juices at the end of
eradication treatment
MUC 1 vs. Lewis b 0.44* 0.18*
sialyl Lewis x 0.75* -0.07*
H type 1 0.39 0.87*
Structure recognized by MAA -0.11* -0.74*
Structure recognized by SNA 0.3* 0.13
Structure recognized by AAA 0.18* 0.17*
Structure recognized by UEA 0.23* 0.31*
Structure recognized by LTA 0.55* -0.14
Structure recognized by PNA -0.24* -0.46*
Structure recognized by VVA -0.37* -0.48*
Structure recognized by DSA 0.11* -0.4
Structure recognized by NPA 0.49 -0.32*
Structure recognized by GNA 0.62 -0.26
MUC 5AC vs. Lewis b 0.27* 0.46*
sialyl Lewis x 0.46 0.011*
H type 1 0.5* 0.13
Structure recognized by MAA 0.66* -0.13*
Structure recognized by SNA 0.47 0.46
Structure recognized by AAA -0.3* -0.16*
Structure recognized by UEA 0.39* 0.32*
Structure recognized by LTA 0.8 0.48
Structure recognized by PNA -0.26* 0.033*
Structure recognized by VVA 0.18* 0.16*
Structure recognized by DSA 0.005 -0.26
Structure recognized by NPA -0.2 -0.3*
Structure recognized by GNA 0.24 -0.28
86 Clin Exp Med (2011) 11:81–88
123
The influence of omeprazole alone on examined struc-
tures also cannot be excluded. It is said that pH change
(after omeprazole treatment) in Helicobacter pylori envi-
ronment can result in its affinity to mucins, and bacteria
cannot remain efficiently bound to mucus and are flushed
away [12, 15, 24]. However, this was not examined in the
present study.
From our results, we are not able to tell which of the
glycan epitopes are present in which mucin. We can only
suggest that H type 1 structure comes mostly from MUC 1
mucin as correlations between them in both groups of
patients examined were positive (on moderate and high
level). Similar assumptions can be taken for MUC 5 AC
and Lewis b, SA a 2–6, Fuc a 1–3, and a 1–2 linkages
because of positive values of Pearson’s coefficients.
However, we should emphasize that above sugar structures
can be also present in other glycoproteins not examined in
this study. So we state that our concepts should be sup-
ported by more detailed examinations.
In conclusion, the observed changes in glycosylation
pattern induced by H. pylori support the idea about the
involvement of mucins and other glycan structures in the
mechanism of the infection. We suggest that the knowledge
about the exact action of the bacterium could contribute to
looking for new therapeutic strategies.
Conflict of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S,
Pignatelli M (2000) Mucins and mucosal protection in the gas-
trointestinal tract: new prospects for mucins in the pathology of
gastrointestinal disease. Gut 47:589–594
2. Uemura N, Okamoto S, Yamamoto S et al (2001) Helicobacter
pylori infection and the development of gastric cancer. N Engl J
Med 11:784–789
3. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA
(2008) Mucins in the mucosal barrier to infection. Mucosal
Immunol 1:183–197
4. Nordman H, Davies JR, Lindell G, de Bolos C, Real F, Carlstedt I
(2002) Gastric MUC 5AC and MUC 6 are large oligomeric
mucins that differ in size, glycosylation and tissue distribution.
Biochem J 364:191–200
5. Gendler SJ (2001) MUC 1, the renaissance molecule. J Mammary
Gland Biol Neoplasia 6:339–353
6. Orczyk-Pawiłowicz M, Florian´ski J, Zalewski J, Ka˛tnik-Pra-
stowska I (2005) Relative amounts of sialic acid and fucose of
amniotic fluid glycoconjugates in relation to pregnancy age.
Glycoconjugate J 22:433–442
7. Linden S, Mahdavi J, Hedenbro J, Boren T, Carlstedt I (2004)
Effects of pH on Helicobacter pylori binding to human gastric
mucins; identification of binding to non-MUC 5AC mucins.
Biochem J 384:263–270
8. Bovenkamp JHB, Mahdavi J, Korteland-Van Male AM et al (2003)
The MUC 5AC glycoprotein is the primary receptor for Helico-
bacter pylori in the human stomach. Helicobacter 8:521–532
9. Linden S, Nordman H, Hedenbro J, Hurtig M, Boren T, Carlstedt
I (2002) Strain- and blood group—dependent binding of Heli-
cobacter pylori to human gastric MUC 5AC glycoforms. Gas-
troenterology 123:1923–1930
10. Mahdavi J, Sonden B, Hurtig M et al (2002) Helicobacter pylori
SabA adhesin in persistent infection and chronic inflammation.
Science 297:573–578
11. Ilver D, Arnaqvist A, }Orgen J et al (1998) Helicobacter pylori
adhesin binding fucosylated histo-blood group antigens revealed
by retagging. Science 279:373–377
12. Sheu BS, Odenbreit S, Hung KH et al (2006) Interaction between
host gastric sialyl-Lewis x and H. pylori SabA enhances H. pylori
density in patients lacking gastric Lewis b antigen. Am J Gas-
troenterol 101:36–44
13. McGuckin MA, Every AL, Skene CD, Linden SK et al (2007)
Muc 1 mucin limits both Helicobacter pylori colonization of the
murine gastric mucosa and associated gastritis. Gastroenterology
133:1210–1218
14. Ota H, Nakayama J, Momose M et al (1998) Helicobacter pylori
infection produces reversible glycosylation changes to gastric
mucins. Virchows Arch 433:419–426
15. Radziejewska I, Borzym-Kluczyk M, Kisiel DG, Namiot Z,
Wosek J, Gindzien´ski A (2008) The effect of Helicobacter pylori
eradication tratment on the MUC 1 and Lewis antigens level in
human gastric juice: a preliminary study. Dig Dis Sci 53:2641–2645
16. Smith PK, Krohn RJ, Hermanson GT (1985) Measurement of
protein using bicinchoninic acid. Anal Chem 150:76–85
17. Hanisch FG, Muller S (2000) MUC 1: the polymorphic appear-
ance of human mucin. Glycobiology 10:439–449
18. Cooke CL, An HJ, Kim J et al (2009) Modification of gastric
mucin oligosaccharide expression in rhesus macaques after infec-
tion with Helicobacter pylori. Gastroenterology 137:1061–1071
19. Byrd JC, Yunker CK, Xu Q-S, Sternberg LR, Bresalier RS (2000)
Inhibition of gastric mucin synthesis by Helicobacter pylori.
Gastroenterology 118:1072–1079
Fig. 5 Schematic illustration of the suggested sequence of events
leading to changes occurring during Helicobacter pylori infection
Clin Exp Med (2011) 11:81–88 87
123
20. Kocer B, Ulas M, Ustundag Y et al (2004) A confirmatory report
for the close interaction of Helicobacter pylori with gastric epi-
thelial MUC 5AC expression. J Clin Gastroenterol 38:496–502
21. Radziejewska I, Kisiel DG, Borzym-Kluczyk M, Kluz A, Namiot
Z, Gindzien´ski A (2007) MUC 1 mucin kontent in gastric juice of
duodenal ulcer patients: effect of Helicobacter pylori eradication
therapy. Clin Exp Med 7:72–76
22. Linden S, Wickstrom C, Lindell G, K Gilshenan, Carlstedt I (2008)
Four models of adhesion are used during Helicobacter pylori binding
to human mucins in the oral and gastric niches. Helicobacter
13:81–93
23. Linden S, Sheng Y, Every A et al (2009) MUC 1 limits Heli-
cobacter pylori infection both by steric hindrance and by acting
as releasable decoy. PLoS Pathog 5:e1000617
24. Radziejewska I, Gindzien´ski A, Wosek J, Ko _zuszyn´ska-Topo´r M,
Namiot Z (2004) The influence of omeprazole treatment on MUC
1 mucin contents in gastric juice of Helicobacter pylori infected
patients. Gastroenterol Pol 11:435–438
25. Yamashita K, Kochibe N, Ohkura T, Ueda I, Kobata A (1985)
Fractionation of L-fucose-containing oligosaccharides on immo-
bilized Aleuria auranta lectin. J Biol Chem 260:4688–4693
26. Audette GF, Vandonselaar M, Delbaere LTJ (2000) The 2.2 A˚
resolution structure of the O(H) blood-group-specific Lectin I
from Ulex europaeus. J Mol Biol 304:423–433
27. Yan L, Wilkins PP, Alvarez-Manilla G, Do SI, Smith DF,
Cummings RD (1997) Immobilized Lotus tetragonolobus
agglutinin binds oligosaccharides containing the Lex determinant.
Glycoconjugate J 14:45–55
28. Wang WC, Cummings RD (1988) The immobilized leukoag-
glutinin from the seeds of Maackia amurensis binds with high
affinity to complex-type Asn-linked oligosaccharides containing
terminal sialic acid-linked alpha-2, 3 to penultimate galactose
residues. J Biol Chem 263:4576–4585
29. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Pe-
eters B, Peumans WJ (1987) The elderberry (Sambucus nigra L.)
bark lectin recognizes the Neu5Ac (alpha 2–6) Gal/GalNAc
sequence. J Biol Chem 262:1596–1601
30. Sharma V, Vijayan M, Surolia A (1996) Imparting equisite
specificity to peanut agglutinin for the tumor-associated Thom-
sen-Friedenreich antigen by redesign of its combining site. J Biol
Chem 271:1209–21213
31. Wu AM (2004) Polyvalency of Tn (GalNAca ? Ser/Thr) gly-
cotope as a critical factor for Vicia villosa B4 and glycoprotein
interactions. FEBS Lett 562:51–58
32. Taketa K, Ichikawa E, Yamamoto T et al (1990) Datura stra-
monium agglutinin-reactive alpha-fetoprotein isoforms in hepa-
tocellular carcinoma and other tumors. Tumour Biol 11:220–228
33. Lopez S, Codina C, Bastida J, Viladomat F, Davidson E, Stewart
D (2002) Biodiversity of mannose-specific lectins within Nar-
cissus species. J Agric Food Chem 50:2507–2513
34. Pusztai A, Grant G, Spencer RJ et al (1993) Kidney bean lectin-
induced Escherichia coli overgrowth in the small intestine is
blocked by GNA, a mannose-specific lectin. J Appl Bacteriol
75:360–368
88 Clin Exp Med (2011) 11:81–88
123
